Back to top
more

Bruker (BRKR)

(Delayed Data from NSDQ)

$63.32 USD

63.32
931,004

-0.05 (-0.08%)

Updated Sep 10, 2024 04:00 PM ET

After-Market: $63.32 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Instruments - Scientific

Better trading starts here.

Zacks News

Bruker (BRKR) Up 6.8% Since Last Earnings Report: Can It Continue?

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Should You Consider Retaining Bruker Stock in Your Portfolio Now?

BRKR's robust growth potential across its major segments is encouraging. Yet, macro woes and competitive pressure can pose challenges.

Bruker (BRKR) Rolls Out the First 1.2 GHz NMR System in Asia

Bruker (BRKR) installs the 1.2 GHz Avance NMR Spectrometer at KBSI, enabling advanced scientific discoveries.

Bruker (BRKR) Reliance on International Sales: What Investors Need to Know

Evaluate Bruker's (BRKR) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Bruker (BRKR) Partners With NovAliX to Boost Drug Discovery

Bruker (BRKR) invests in NovAliX to accelerate advancements in drug discovery, combining cutting-edge biophysical methods and technologies to develop new treatments and enhance biopharma solutions.

Bruker (BRKR) Q2 Earnings Meet Mark, '24 Revenue Outlook Raised

Bruker (BRKR) delivers robust revenue growth in the second quarter despite soft general market conditions.

Compared to Estimates, Bruker (BRKR) Q2 Earnings: A Look at Key Metrics

The headline numbers for Bruker (BRKR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Is the Options Market Predicting a Spike in Bruker (BRKR) Stock?

Investors need to pay close attention to Bruker (BRKR) stock based on the movements in the options market lately.

Bruker (BRKR) Q2 Earnings Meet Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 0% and 0.56%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Industry Outlook Mettler-Toledo and Bruker

Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.

Aniruddha Ganguly headshot

2 Instruments Stocks to Watch From a Prospering Industry

The Zacks Instruments - Scientific industry participants like MTD and BRKR are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.

Gear Up for Bruker (BRKR) Q2 Earnings: Wall Street Estimates for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Bruker (BRKR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.

Urmimala Biswas headshot

What's in Store for These 4 MedTech Stocks in Q2 Earnings?

Here is a sneak peek into how four MedTech companies, LH, BIO, TFX and BRKR, are expected to fare in their second-quarter results, slated to be released tomorrow.

Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Bruker (BRKR) Beat Estimates Again in Its Next Earnings Report?

Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Bruker (BRKR) Banks on End Market Growth Amid Macro Headwinds

Bruker's (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand.

Bruker (BRKR) Expands in NMR Spectrometry With New FMP Collab

Bruker (BRKR) completes the installation of its 1.2 (GHz) Avance nuclear magnetic resonance (NMR) spectrometer at the Leibniz Forschungsinstitut f??r Molekulare Pharmakologie in Berlin.

Bruker's (BRKR) Strategic Buyouts Aid Amid Macroeconomic Woes

Bruker's (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand, further bolstered by the addition of Inscopix's neuroscience research tools.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Smart Beta ETF report for FBT

Bruker (BRKR) Launches neofleX MALDI-TOF/TOF MSI System

Bruker's (BRKR) neofleX is a versatile, high-performance and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers.

Bruker (BRKR) Gains Market Share on Innovation Amid Macro Woes

Bruker's (BRKR) BSI Nano business is seeing robust revenue growth across its end markets, including academic, government, industrial and semiconductor metrology.

Zacks Industry Outlook Highlights Mettler-Toledo and Bruker

Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.

Aniruddha Ganguly headshot

2 Instruments Stocks to Watch From a Prospering Industry

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.

Investing in Bruker (BRKR)? Don't Miss Assessing Its International Revenue Trends

Examine Bruker's (BRKR) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.